Source: Annual Congress 2007 - Sarcoidosis: various aspects



Rating:

Share or cite this content

Citations should be made in the following way:
G. Jonker, M. Elfferich, E. Lower, R. Baughman, M. Drent, J. De Vries (Eindhoven, Maastricht, Tilburg, Netherlands; Cincinnati, United States Of America). Fatigue in sarcoidosis; comparing American and Dutch patients. Eur Respir J 2007; 30: Suppl. 51, 806

Member's Comments

No comment yet.

Related content which might interest you: Severity of airflow obstruction using NHANESIII versus ERS/GLI12 prediction equations in Caucasian American pulmonary laboratory patients Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages Year: 2014 Validation of a Japanese version of the COPD diagnostic questionnaire in the general Asian population: The Hisayama study Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Spirometry is associated with management of COPD patients in five Latin American cities: PLATINO study Source: Annual Congress 2007 - Respiratory issues in primary care Year: 2007 Screening for COPD using the Canadian Lung Association questionnaire: A practice assessment of Canadian physicians Source: Annual Congress 2010 - Comorbidities and disease management in primary care Year: 2010 Prevalence of respiratory symptoms in subjects with and without COPD in 5 Latin American cities: the PLATINO study Source: Annual Congress 2007 - Environmental and clinical aspects of COPD Year: 2007 Responsiveness of the Dutch version of the London chest activity of daily living scale (LCADL) in patients with severe COPD Source: International Congress 2015 – Respiratory physiotherapy assessment and techniques in COPD and asthma Year: 2015 Diagnostic sensitivity of a symptom-based questionnaire, the Canadian Lung Health Test (CLHT), in subjects at risk for COPD Source: Eur Respir J 2005; 26: Suppl. 49, 514s Year: 2005 Evaluation of respiratory symptoms in COPD patients from seven Latin America countries: The LASSYC Study Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 Asthma, COPD and overlap syndrome: a longitudinal study in young European adults Source: Eur Respir J 2015; 46: 671-679 Year: 2015 Prevalence of dyspepsia in COPD patients: Experience in a large Canadian cohort Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable Year: 2011 Clinical description of a population of Dutch IPF patients Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Validation of the Clinical COPD Questionnaire (CCQ) in Swedish primary care Source: Eur Respir J 2005; 26: Suppl. 49, 671s Year: 2005 Evaluation of omalizumab therapy in a Chinese versus predominantly Caucasian population: Comparison of clinical data Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 The burden of asthma in Canadian children and adolescents of South Asian descent Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Comfort in diagnosing COPD: A survey of Canadian physicians Source: Annual Congress 2010 - From diagnosis to disease management in primary care Year: 2010 Employment in subjects with and without COPD in five Latin American cities: The PLATINO study Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD Year: 2010 Impact of COPD and its comorbidities on exercise capacity (presentation in Spanish by SEPAR representative) Source: International Congress 2015 – Spanish/Portuguese Day: Exercise and other lifestyle behaviour for good lung health worldwide Year: 2015 Comparison of lung function in Congolese vs African American children Source: International Congress 2016 – What's new in paediatric respiratory physiology? Year: 2016 Disease characteristics and outcomes in a Swedish cohort of patients with pulmonary fibrosis (PF) Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018